Myocardial Solutions
Medical Equipment Manufacturing • 
4819 Emperor Blvd, Suite 140, United States • 21-50 Employees
Company overview
| Headquarters | 4819 Emperor Blvd, Suite 140, Durham, North Carolina 27703, US |
| Phone number | +19196778100 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Personalized Medicine, Patient Management, Oncology, Stress Testing, Cancer Care, Cardiac Mri, Heart Failure Management, Long-Term Monitoring, Value-Based Care, Early Detection, Cardio-Oncology, Preventative Cardiology, Covid 19, Cardio-Protection, Chest Pain Triage, Proactive Diagnostics, Rapid Heart Function Testing, Non-Invasive And Safe Test |
| Founded | 2016 |
| Employees | 21-50 |
| Socials |
Key Contact at Myocardial Solutions
Luis Suarez
Medical Director
Myocardial Solutions Email Formats
Myocardial Solutions uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@myocardialsolutions.com), used 82.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@myocardialsolutions.com | 82.4% |
{first name}.{last name} | john.doe@myocardialsolutions.com | 17.6% |
About Myocardial Solutions
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, non-invasive heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. This novel cardiac tool leverages the power of high-speed MR imaging to help physicians detect and measure the effects of cardiotoxicity during cancer treatments. Physicians are using MyoStrain as a critical solution to holistically evaluate and protect patient heart health without interfering with oncology care. Today, with mounting evidence that many oncology treatments cause cardiotoxicity, new cancer patients and survivors are at an increased risk of cardiovascular disease. Unfortunately, diagnostics often cannot detect cardiotoxicity until symptoms occur, which is usually a sign of cardiac damage. The MyoStrain test works by quantifying segmental strain across 48 segments of the heart. This safe and rapid test produces a comprehensive report and MyoHealth™ Score, a single number that helps indicate patient heart health and enables physicians to manage cardio-protection over time. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
Myocardial Solutions revenue & valuation
| Annual revenue | $2,000,000 |
| Revenue per employee | $58,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $6,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Myocardial Solutions has 18 employees across 7 departments.
Departments
Number of employees
Funding Data
Myocardial Solutions has never raised funding before.
Myocardial Solutions Tech Stack
Discover the technologies and tools that power Myocardial Solutions's digital infrastructure, from frameworks to analytics platforms.
CDN
Widgets
CDN
JavaScript libraries
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
Translation
CRM
Page builders
Cookie compliance
Canada
South Africa
Saudi Arabia
Australia
FranceFrequently asked questions
4.8
40,000 users
